Alnylam CEO backs inflation-based drug price hikes, welcomes Amazon's foray into health care
November 30, 2017 at 14:35 PM EST
Before the approval of Alnylam's first drug, CEO John Maraganore backed the idea of raising prices pegged to inflation.
